<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03327623</url>
  </required_header>
  <id_info>
    <org_study_id>17-003514 16-009474</org_study_id>
    <secondary_id>1R01HL134885-01</secondary_id>
    <secondary_id>FP00093543</secondary_id>
    <nct_id>NCT03327623</nct_id>
  </id_info>
  <brief_title>Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)</brief_title>
  <official_title>A Prevalence and Incidence Study Investigating the Burden of Atrial and Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy and Sleep Apnea.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are trying to find out how common sleep apnea is in hypertrophic
      cardiomyopathy. The purpose of this study is to see if sleep apnea is common in hypertrophic
      cardiomyopathy and if its presence is associated with changes in the functioning of the body.
      The investigators want to determine if sleep apnea is associated with electrical disorders of
      the heart in patients with hypertrophic cardiomyopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be healthy volunteers or subjects with the diagnosis of hypertrophic
      cardiomyopathy (HCM). All patients will a undergo a one time; medical history, physical
      examination, questionnaires, sleep observation in hospital, blood and urine samples,
      ultrasound scan of the heart, paced breathing test, ultrasound of brachial artery in the arm,
      MRI of the heart &amp; 48 hour ECG Holter monitoring. Comparison between the normal volunteers
      and subjects with HCM will be made.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 13, 2017</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of Obstructive Sleep Apnea (OSA).</measure>
    <time_frame>Approximately 2 years.</time_frame>
    <description>Measured by the Apnea-hypopnea index (AHI). The AHI is the number of apneas or hypopneas recorded during the study per hour of sleep. It is generally expressed as the number of events per hour. Based on the AHI, sleep apnea is diagnosed if an AHI ≥5 events/hour.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine the severity of Sleep Apnea.</measure>
    <time_frame>Approximately 2 years.</time_frame>
    <description>The severity of OSA is classified based on the AHI as follows: None/Minimal: AHI &lt; 5 per hour, Mild: AHI ≥ 5, but &lt; 15 per hour, Moderate: AHI ≥ 15, but &lt; 30 per hour, Severe: AHI ≥ 30 per hour.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Differences in Autonomic Regulation.</measure>
    <time_frame>Approximately 2 years.</time_frame>
    <description>In persons with hypertrophic cardiomyopathy and sleep apnea vs. those without sleep apnea.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of atrial arrhythmias.</measure>
    <time_frame>Approximately 2 years.</time_frame>
    <description>Investigators will determine prevalence of atrial arrhythmias, based on prior ECG documented atrial arrhythmias at any timepoint prior to enrolment and up to 4 weeks after the study date. Participants will also have a 48h ECG (extended Holter) recorder attached to screen for atrial arrhythmias.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of atrial arrhythmias.</measure>
    <time_frame>Approximately 5 years.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Frequency of ventricular arrhythmias.</measure>
    <time_frame>Approximately 5 years.</time_frame>
    <description>Investigators will prospectively follow patients with hypertrophic cardiomyopathy to determine the frequency of ventricular arrhythmias in those with vs those without sleep apnea.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Identify novel biomarkers</measure>
    <time_frame>Approximately 5 years</time_frame>
    <description>Participants will be prospectively followed and blood collected to identify biomarkers of arrhythmia, heart failure and prognosis in persons with hypertrophic cardiomyopathy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigate the association of sleep apnea with atrial and ventricular fibrosis</measure>
    <time_frame>Approximately 7 years</time_frame>
    <description>Participants will undergo baseline MRI studies of the heart to determine the burden of fibrosis and its association with sleep apnea. Participants may be invited to complete a follow-up study to track changes in fibrosis.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">662</enrollment>
  <condition>Hypertrophic Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Hypertrophic Cardiomyopathy (HCM)</arm_group_label>
    <description>Subjects with a diagnosis of Hypertrophic Cardiomyopathy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Subjects who are healthy volunteers</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood plasma, serum and urine.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers and Subjects from The Mayo Clinic Hypertrophic Cardiomyopathy (HCM)
        Registry who reside in Minnesota.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Able to consent

          -  Non-pregnant

        Exclusion criteria:

          -  Decompensated Heart failure (symptoms and N-terminal pro b-type natriuretic peptide
             (NT-proBNP) &gt;332 ng/L in the absence of renal failure or competing cause)

          -  Prior alcohol septal ablation

          -  Surgical myectomy

          -  Prosthetic valves

          -  Current smokers or recently quit (&lt;6 months)

          -  Chronic obstructive pulmonary disease (COPD) (FEV1/Forced vital capacity (FVC) &lt;0.70;
             FEV1 &lt;80%)

          -  Known autonomic dysfunction

          -  (Fully) Treated sleep apnea (mandibular device, CPAP)

          -  Vulnerable study population

          -  Prior catheter ablation for atrial fibrillation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Virend Somers, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lisa D. Block</last_name>
    <phone>507 255 0492</phone>
    <email>cpl@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anwar A Chahal, MB ChB MRCP</last_name>
    <phone>507 255 1272</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa D Block</last_name>
      <phone>507-255-8794</phone>
      <email>CPL@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Virend K Somers, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anwar A Chahal, MBChB MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meghna P Mansukhani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard J Gersh, MBChB DPhil</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffrey B Geske, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steve R Ommen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter A Brady, MD FRCP FHRS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sean M Caples, DO MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik K St Louis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Grace Lin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Olson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wolfgand Singer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 25, 2017</study_first_submitted>
  <study_first_submitted_qc>October 30, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>March 5, 2018</last_update_submitted>
  <last_update_submitted_qc>March 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Virend Somers</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>sleep apnea</keyword>
  <keyword>arrhythmia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

